These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9717768)

  • 21. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression.
    Kennett GA; Dourish CT; Curzon G
    Eur J Pharmacol; 1987 Feb; 134(3):265-74. PubMed ID: 2883013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of subchronic lithium carbonate treatment on anxiolytic-like effect of citalopram and MKC-242 in conditioned fear stress in the rat.
    Muraki I; Inoue T; Hashimoto S; Izumi T; Ito K; Ohmori T; Koyama T
    Eur J Pharmacol; 1999 Nov; 383(3):223-9. PubMed ID: 10594313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a benzodioxan derivative MKC-242 on the firing activity of the dorsal hippocampus CA1 pyramidal neurons in awake and urethane- anaesthetized rats: in vivo electrophysiological evidence for a 5-HT 1A agonistic property.
    Kasamo K; Suzuki T; Tada K; Ueda N; Matsuda E; Kojima T
    Int J Neuropsychopharmacol; 2000 Jun; 3(2):99-108. PubMed ID: 11343586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
    Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional alteration of brain dopaminergic system in isolated aggressive mice.
    Matsuda T; Sakaue M; Ago Y; Sakamoto Y; Koyama Y; Baba A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Sep; 21(3):71-6. PubMed ID: 11769459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM; Vilaró MT; Mengod G; Artigas F
    J Neurochem; 1999 Jan; 72(1):262-72. PubMed ID: 9886078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
    Truitt W; Harrison L; Guptarak J; White S; Hiegel C; Uphouse L
    Brain Res; 2003 Jun; 974(1-2):202-11. PubMed ID: 12742638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of serotonin-1A receptors in restraint-induced behavioral deficits and adaptation to repeated restraint stress in rats.
    Haleem DJ; Samad N; Perveen T; Haider S; Haleem MA
    Int J Neurosci; 2007 Feb; 117(2):243-57. PubMed ID: 17365111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of (R)- and (S)-8-hydroxy-2-(di-n-propylamino)tetralin on the monosynaptic spinal reflex in rats.
    Honda M; Ono H
    Eur J Pharmacol; 1999 Jun; 373(2-3):171-9. PubMed ID: 10414436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the selective 5-HT1A receptor antagonist WAY100135 and its enantiomers on 8-OH-DPAT-induced hyperglycaemia in conscious rats.
    Critchley DJ; Middlefell VC; Liddle CW; Foden ND; Dourish CT
    Eur J Pharmacol; 1994 Mar; 254(1-2):133-9. PubMed ID: 8206109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation by 5-hT2A receptors of aggressive behavior in isolated mice.
    Sakaue M; Ago Y; Sowa C; Sakamoto Y; Nishihara B; Koyama Y; Baba A; Matsuda T
    Jpn J Pharmacol; 2002 May; 89(1):89-92. PubMed ID: 12083749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties.
    Assié MB; Koek W
    Eur J Pharmacol; 1996 May; 304(1-3):15-21. PubMed ID: 8813579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characterization of LY293284: A 5-HT1A receptor agonist with high potency and selectivity.
    Foreman MM; Fuller RW; Rasmussen K; Nelson DL; Calligaro DO; Zhang L; Barrett JE; Booher RN; Paget CJ; Flaugh ME
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1270-81. PubMed ID: 7523657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.